Skip to main content
MUSTANG BIO, INC. logo

MUSTANG BIO, INC. — Investor Relations & Filings

Ticker · MBIO ISIN · US62818Q1040 LEI · 5493004W0VC1DPECQ779 US Manufacturing
Open in API
Filings indexed 399 across all filing types
Latest filing 2021-04-20 Proxy Solicitation & In…
Country US United States of America
Listing US MBIO

About MUSTANG BIO, INC.

https://www.mustangbio.com/

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel cell and gene therapies. The company's primary focus is on translating medical breakthroughs into potential cures for difficult-to-treat cancers and rare genetic diseases. Its pipeline is centered on Chimeric Antigen Receptor (CAR) T-cell therapies, a form of immunotherapy. Mustang Bio's strategy involves in-licensing promising technologies from academic institutions and advancing them through clinical trials, supported by its in-house manufacturing capabilities to ensure the production and delivery of these advanced treatments.

Recent filings

Filing Released Lang Actions
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. It includes detailed information about the upcoming Annual Meeting of Stockholders, including proposals to be voted on, director elections, amendments to corporate documents, and other shareholder matters. It also references the availability of the annual report but does not contain the report itself. The document is not a full annual report, earnings release, or other financial report but is specifically a proxy solicitation document for the annual meeting. Therefore, it fits the category of Proxy Solicitation & Information Statement (PSI). The document length and content confirm it is the proxy statement itself, not just an announcement or notice.
2021-04-20 English
OWNERSHIP DOCUMENT
Director's Dealing
2021-04-16 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-04-10 English
FORM S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used for registering securities to be offered under employee benefit plans such as stock purchase plans. It includes detailed information about the securities to be registered, indemnification of directors and officers, incorporation by reference of other SEC filings, and exhibits related to the registration. It is not a financial report, earnings release, or management discussion, but a regulatory filing related to securities registration under the Securities Act of 1933. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is the registration statement itself, not just an announcement or certification.
2021-04-02 English
10-K
Annual Report FY 2020
2021-03-24 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 24, 2021, by Mustang Bio, Inc. It announces the issuance of a press release providing a corporate update and financial results for the fiscal year ended December 31, 2020. The document itself is short (3286 characters) and primarily serves to furnish the press release as an exhibit. There are no detailed financial statements or substantive financial data within this text, only a reference to the press release. According to the 'Menu vs Meal' rule, this is an announcement of financial results rather than the full earnings release or annual report itself. Therefore, the appropriate classification is Earnings Release (ER), as the press release contains the initial announcement of financial results for the fiscal year.
2021-03-24 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.